Severe asthma is highly complex and differs from person to person.
Experts are currently trying to find biological markers in people with severe asthma that indicate different versions of the disease. If experts can identify these markers, it will improve diagnosis of different kinds of severe asthma and help develop treatments that are most suited to different versions of the condition.
A new review, published in the European Respiratory Journal, as part of the U-BIOPRED project, has reviewed the various technologies (also known as 'omics') that exist to help identify these biological markers.
The review analyses six different technologies and different approaches to identifying biomarkers. It looks at each approach, their strengths and weaknesses and their ability to contribute to studies of lung conditions.